Resultados da Busca
- 1
- 2
- > Seguinte
-
Anna-Lena Engwall - Global Commercial Vice President & Franchise Head Cardiovascular & Renal, Metabolic - posee un Bachelor of Science in Nursing de Karolinska Institute.AstraZeneca - Farmacêutica - Reino Unido
-
Johan Luthman - Executive Vice President, Research and Development - has a PhD, Basic Dentistry, Medicine and Neuroscience from Karolinska Institute and Doctor of Dental Surgery from Karolinska Institute.Lundbeck - Farmacêutica - Dinamarca
-
Jakob Loven - Director - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.Arrakis Therapeutics - Biotecnologia - Estados Unidos
-
Jan Lundberg - Director - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.Anocca - Biotecnologia - Suécia
-
Anders Ekblom - Chairman of the Board - has a Doctor of Medicine from Karolinska Institute and PhD in Physiology from Karolinska institutet Degree NamePhDField Of StudyPhysiology.Alligator Bioscience - Biotecnologia - Suécia
-
Yilmaz Mahshid - Director - has a PhD in Medical Biochemistry and Biophysics from Karolinska Institute and Master in Toxicology from Karolinska Institute.Malene Jensen - Vice President, Clinical Development - has a PhD in Clinical Neuroscience from Karolinska Institute and Master of Science in Molecular Biology from Stockholm University.Pia Baumann - Chief Medical Officer - posee un PhD in Oncology de Karolinska Institute.Medivir - Biotecnologia - Suécia
-
Per Lundin - Chief Executive Officer and Director - has a PhD in Medical Science from Karolinska Institute and Licentiate in Neurochemistry from Stockholm University.Evox Therapeutics - Biotecnologia - Reino Unido
-
Anders Ekblom - Non-Executive Director - has a Doctor of Medicine from Karolinska Institute and PhD in Physiology from Karolinska institutet Degree NamePhDField Of StudyPhysiology.Mereo BioPharma - Farmacêutica - Reino Unido
-
Jakob Loven - Board Member - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.IconOVir Bio - Biotecnologia - Estados Unidos
-
Jan Lundberg - Independent Director - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.Metabolon - Biotecnologia - Estados Unidos
-
Yilmaz Mahshid - Chief Financial Officer - has a PhD in Medical Biochemistry and Biophysics from Karolinska Institute and Master in Toxicology from Karolinska Institute.Desiree Luthman - Vice President, Global Regulatory Affairs - posee un Doctor of Dental Surgery de Karolinska Institute.Egetis Therapeutics - Biotecnologia - Suécia
-
Per Grufman - Chief Executive Officer, Biocrucible - has a PhD in Immunology from Karolinska Institute and Master of Science in biology from Stockholm University.Sapphiros - Biotecnologia - Estados Unidos
-
Mikael Nygard - Chief Operating Officer - has a PhD in Neuroscience from Karolinska Institute and Master of Sciences in Pharmacy from Uppsala University.Vicore Pharma - Farmacêutica - Suécia
-
Hans Basun - Senior Director Clinical Development - posee un Medical Doctorate de Karolinska Institute.Anna-Lena Engwall - Director - posee un Bachelor of Science in Nursing de Karolinska Institute.BioArctic - Biotecnologia - Suécia
-
Per Grufman - Chief Executive Officer - has a PhD in Immunology from Karolinska Institute and Master of Science in biology from Stockholm University.Biocrucible - Biotecnologia - Reino Unido
-
Jan Lundberg - Board Member - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.AlzeCure Pharma - Farmacêutica - Suécia
-
Johan Lof - Founder, Chief Executive Officer, President and Director - has a PhD from Karolinska Institute and Master of Science in Engineering from Royal Institute of Technology.Raysearch Laboratories - Serviços Ambientais - Suécia
-
Roger Tell - Chief Medical Officer - has a Phd, Experimental Oncology from Karolinska Institute and Medical Doctorate from Karolinska Institute.Isofol Medical - Farmacêutica - Suécia
-
Claes Lindh - Chief Medical Officer - posee un PhD in Prostate Cancer Pathology de Karolinska Institute.Inify Laboratories - Biotecnologia - Suécia
-
Kjell Stenberg - Chief Executive Officer - has a Doctor of Medical Science in Cellular Toxicity from Karolinska Institute and Master of Science in Biochemical Separation Technologies from Umeå University.Cyxone - Farmacêutica - Suécia
-
Jakob Loven - Director - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.Hexagon Bio - Biotecnologia - Estados Unidos
-
Jarl Jungnelius - Board Member - posee un Doctor of Medicine de Karolinska Institute.Oncopeptides - Biotecnologia - Suécia
- 1
- 2
- > Seguinte